Skip to main content
SpringerLink
Log in

Recent advances in the pathogenesis and nutritional treatment of chronic uremia

  • Übersicht
  • Published:
Zeitschrift für Ernährungswissenschaft Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abiko, T., M. Kumikawa, H. Higuchi, H. Sekino: Identification and synthesis of a heptapeptide in uremic fluid. Biochem. Biophys. Res. Commun.84, 184–194 (1978).

    Article  CAS  Google Scholar 

  2. Abiko, T., I. Onodera, H. Sekino: Isolation, structure and biological activity of the Trp-containing pentapeptide from uremic fluid. Biochem. Biophys. Res. Commun.89, 813–821 (1979).

    Article  CAS  Google Scholar 

  3. Abiko, T., M. Kumikawa, M. Ishizaki, H. Takahashi, H. Sekino: Identification and synthesis of a tripeptide in ecum fluid of an uremic patient. Biochem. Biophys. Res. Commun.83, 357 (1978).

    Article  CAS  Google Scholar 

  4. Abiko, T., I. Onodera, H. Sekino: Characterization of an acidic tripeptide in neurotoxic dialysate. Chem. Pharm. Bull.28, 1629–1633 (1980).

    Article  CAS  Google Scholar 

  5. Alvestrand, A., J. Bergström, P. Fürst, G. Germanis, U. Widstam: The effect of essential amino acid supplementation on muscle and plasma free amino acids in chronic uremia. Kidney Int.14. 323–329 (1978).

    Article  CAS  Google Scholar 

  6. Alvestrand, A., J. Bergström, P. Fürst: Intracellular free amino acids in patients treated with regular hemodialysis (HD). Proc. EDTA16, 129–134 (1979).

    CAS  Google Scholar 

  7. Alvestrand, A., M. Ahlberg, P. Fürst, J. Bergström: Clinical experience with amino acid and keto acid diets. Amer. J. Clin. Nutr.33, 1654–1659 (1980).

    CAS  Google Scholar 

  8. Attman, P. O., A. Gustafson: Lipid and carbohydrate metabolism in uremia. Influence of treatment with protein-reduced diet and essential amino acids. Nutr. Metab.24, 261–266 (1980).

    Article  CAS  Google Scholar 

  9. Bagdade, J. D., P. V. Subbaiah, et al.: Polyamines: An unrecognized cardiovascular risk factor in chronic dialysis? Lancet (1979)I, 412–413.

    Article  Google Scholar 

  10. Bartelson, N. M., T. Basil, A. L. Lavender: 3′5′-cyclic AMP levels in hemodialysis patients. In: Abstracts of 7th Annual Meeting of the American Society of Nephrology7, (1974).

  11. Bazzato, G., C. Mazzina, M. Ciman, et al.: Myasthenia like syndrome associated with carnitine in patients on long-term hemodialysis. Lancet (1979),I, 1041–1042.

    Article  Google Scholar 

  12. Bergström, J., P. Fürst: Uraemic toxins. In: Replacement of renal function by dialysis, Chapter 18, p. 334, W. Drukker, F. M. Pearson, J. F. Maher, edited by Martinus Nijhoff Medical Division. (The Hague-Boston-London 1978).

    Google Scholar 

  13. Bergström, J., A. Alvestrand, H. Asaba, P. Fürst, V. Yahiel, L. Zimmermann: Uremic middle molecules. In: Controversies in Nephrology, Proceedings of the First Conference, edited by G. E. Schreiner, Nephrology Division, Georgetown University, 425–434 (Washington 1979).

    Google Scholar 

  14. Bergström, J., P. Fürst, L. Zimmermann: Uremic middle molecules exist and are biologically active. Clin. Nephrol.11, 229 (1979).

    Google Scholar 

  15. Bergström, J., P. Fürst, L. O. Norée: Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. I. Nitrogen balance studies. Clin. Nephrol,3, 189 (1975).

    Google Scholar 

  16. Bergström, J., P. Fürst, B. Josephson, L. O. Norée: Factors affecting the nitrogen balance in chronic uremic patients receiving essential amino acids intravenously or by mouth. Nutr. Metabol.14, Suppl., 162 (1972).

    Article  Google Scholar 

  17. Bergström, J., P. Fürst, B. Josephson, L. O. Norée: Improvement of nitrogen balance in a uremic patient by the addition of histidine to essential amino acid solutions given intravenously. Life Sci.9, part 2, 787 (1970).

    Article  Google Scholar 

  18. Bergström, J., P. Fürst, L. O. Norée, E. Vinnars: Intracellular free amino acids in muscle tissue of patients with chronic uraemia: effect of peritoneal dialysis and infusion of essential amino acids. Clin. Sci. Mol. Med.54, 51 (1978).

    Google Scholar 

  19. Bergström, J., A. Alvestrand, P. Fürst: Metabolic studies with ketoacids in uremia. Amer. J. Clin. Nutr.31, 1761 (1978).

    Google Scholar 

  20. Borah, M. F., P. Y. Schoenfeld, F. A. Gotch, J. A. Sargent, M. Wolfson, H. Humphreys: Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int.14, 491–500 (1978).

    Article  CAS  Google Scholar 

  21. Broyer, M., G. Jean, A. M. Dartois, C. Kleinknecht: Plasma and muscle free amino acids in children at the early stages of renal failure. Amer. J. Clin. Nutr.33, 1396–1401 (1980).

    CAS  Google Scholar 

  22. Brunner, B., A. Brunner, U. Essers, R. Heintz: Inhibition of bone marrow cell proliferation by undialyzable fraction. In: Renal Insufficience (Würzburg Symposium, 1974), edited by A. Heidland, H. Hennemann and J. Kult. Georg Thieme Verlag (Stuttgart 1976).

    Google Scholar 

  23. Campbell, R. A., Y. B. Talwalkar, D. Bartos, F. Bartos, J. E. Musgrave, M. Harner, D. Grettie, A. M. Dolney, B. Loggan: Polyamines, uremia and hemodialysis. In: Advances in Polyamine Research, vol. 2, p. 319, edited by R. A. Campbell, D. R. Morris, D. Bartos, G. D. Daves and F. Bartos. Raven Press (New York 1978).

    Google Scholar 

  24. Cattran, D. C., G. Steiner, S. S. A. Fenton, et al.: Dialysis hyperlipemia: response to dietary manipulations. Clin. Nephrol.13, 177–182 (1980).

    CAS  Google Scholar 

  25. Clements, R. S., P. V. De Jesus, A. T. Winegrad: Raised plasma myoinositol levels in uraemia and experimental neuropathy. Lancet (1973)I, 1137.

    Article  Google Scholar 

  26. Cueille, G., N. K. Man, A. Sausse, J. P. Farges, J. L. Funck-Brentano: Characterization of sub-peak b4−2, middle molecule. Artif. Organs4 (suppl.), 28 (1980).

    Google Scholar 

  27. De Felice, S. L., M. I. Klein: Carnitine and hemodialysis — a minireview. Current Ther. Res.28, 195–198 (1980).

    Google Scholar 

  28. Delaporte, C., G. Jean, M. Broyer: Free plasma and muscle amino acids in uremic children. Amer. J. Clin. Nutr.31, 1647–1651 (1978).

    CAS  Google Scholar 

  29. Dord, J., M. E. Philips, F. E. Yoye, V. A. Luck, H. E. Wardener: Nitrogen balance in patients with chronic renal failure on diet containing varying quantities of protein. Brit. Med. J. (1969) I, 735.

    Google Scholar 

  30. Dreyfuss, F., R. Chayen, G. Dreyfuss, R. Dvir, J. Ratan: Polyamine excretion in the urine of cancer patients. Israel J. Med. Sci.11, 785 (1975).

    CAS  Google Scholar 

  31. Fürst, P., L. Zimmermann, J. Bergström: Determination of endogenous middle molecules in normal and uremic body fluids. Clin. Nephrol.5, 178–188 (1976).

    Google Scholar 

  32. Fürst, P., A. Alvestrand, J. Bergström: Principles of essential amino acid therapy in uremia. Amer. J. Clin. Nutr.31, 1744–1755 (1978).

    Google Scholar 

  33. Fürst, P.:15N-Studies in severe renal failure. II. Evidence for the essentiality of histidine. Scand. J. Clin. Lab. Invest.30, 307 (1972).

    Article  Google Scholar 

  34. Fürst, P., A. Alvestrand, J. Bergström: Effects of nutrition and catabolic stress on intracellular amino acid pools in uremia. Amer. J. Clin. Nutr.33, 1387–1395 (1980).

    Google Scholar 

  35. Funck-Brentano, J. L., N. K. Man, A. Sausse, J. Zingraff, J. Boudet, A. Becker, G. F. Cueille: Characterization of a 1100–1300 MW uremic neurotoxin. Trans. Amer. Soc. Artif. Intern. Organs22, 163 (1976).

    CAS  Google Scholar 

  36. Giordano, C.: Use of exogenous and endogenous urea for protein synthesis in normal and uraemic subjects. J. Lab. Clin. Med.62, 231 (1963).

    CAS  Google Scholar 

  37. Giordano, C.: Amino acids and ketoacids — advantages and pitfalls. Amer. J. Clin. Nutr.33, 1649–1653 (1980).

    CAS  Google Scholar 

  38. Goldberg, A. P., J. N. Hazberg, J. A. Balmey, et al.: Exercise training improves abnormal lipid carbohydrate metabolism in hemodialysis patients. Trans. ASAIO25, 431–439 (1979).

    Article  CAS  Google Scholar 

  39. Halliday, D., M. Madigan, R. A. Chalmers, P. Purkiss, S. Ell, J. Bergström, P. Fürst, M. Neuhäuser, P. Richards: The degree of conversion of α-keto acids to valine and phenylalanine in health and uremia. Quart. J. Med.197, 53–62 (1981).

    Google Scholar 

  40. Harrison, T. R., M. F. Mason: The pathogenesis of the uremic syndrome. Medicine (Balt)16, 1–44 (1937).

    Article  CAS  Google Scholar 

  41. Herdon, R. F., S. Freeman, A. S. Cleveland: Protein requirements in chronic insufficient patients. A study of the nitrogen minimum. J. Lab. Clin. Med.52, 235 (1958).

    Google Scholar 

  42. Johnson, W. J., W. W. Hagge, R. D. Wagoner, R. P. Dinapoli, J. W. Rosevear: Toxicity arising from urea. Kidney Int.7, Suppl 3, 288 (1975).

    Google Scholar 

  43. Jones, M., J. D. Kopple: Valine metabolism in normal and chronically uremic man. Amer. J. Clin. Nutr.31, 1660–1664 (1978).

    CAS  Google Scholar 

  44. Klein, A., M. Sarnecka-Keller, Z. Hanicki: Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. II. Chief peptide constituents of the fraction. Clin. Chim. Acta90, 7–11 (1978).

    Article  CAS  Google Scholar 

  45. Korz, R., U. Loebnitz, H. Brunner, R. Heintz: Lymphocyte enzymes of DNA-synthesis in chronic renal failure. Proc. Eur. Dial. Transplant Assoc.13, 528 (1976).

    Google Scholar 

  46. Liveson, J. A., J. Gardner, M. B. Bornstein: Tissue culture studies of possible uremic neurotoxins: myoinositol. Kidney Int.12, 131 (1977).

    Article  CAS  Google Scholar 

  47. Lutz, W.: Chemical compositions and rate of passage across semipermeable membranes of basic peptides isolated from peritoneal dialysis fluid from patients with chronic renal failure. Acta Med. Pol.17, 137–147 (1976).

    CAS  Google Scholar 

  48. Massry, S. G.: Is parathyroid hormone a uremic toxin? Nephron19, 125 (1977).

    Article  CAS  Google Scholar 

  49. Munro, H. N.: Amino acid requirements and metabolism and their relevance to parenteral nutrition. In: Parenteral Nutrition, edited by A. W. Wilkinson. Churchill Livingstone (Edinburgh and London 1972).

    Google Scholar 

  50. Norbeck, H. E., L. Orö, L.å. Carlsson: Serum lipid and lipoprotein concentrations in chronic uremica. Acta Med. Scand.200, 487–492 (1976).

    Article  CAS  Google Scholar 

  51. Norée, L. O., J. Bergström: Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. II. Clinical results of long-term treatment. Clin. Nephrol.3, 195 (1975).

    Google Scholar 

  52. Pitkänen, E.: The serum polyol pattern and the urinary polyol excretion in diabetic and in uraemic patients. Clin. Chim. Acts38, 221 (1972).

    Article  Google Scholar 

  53. Prevost, J. L., J. A. Dumas: Examen du sang et du son action dans les divers phénomènes de la vie. Ann. Chim. Phys.23, 90 (1821).

    Google Scholar 

  54. Rabin, E. Z., B. Tattrie, D. Algom, M. Freedman, F. Saunders, D. A. K. Roncari: Ribonuclease activity in renal failure: evidence for toxicity. In: Abstracts of 9th Annual Meeting of the American Society of Nephrology,22 (1976).

  55. Reaven, G. M., R. Swensson, M. L. Sanfelippo: An inquiry into the mechanism of hypertriglyceridemia in patients with chronic renal failure. Amer. J. Clin. Nutr.33, 1476–1484 (1980).

    CAS  Google Scholar 

  56. Rennick, B., M. Acara, P. Hysert, B. Mookerjee: Choline loss during hemodialysis: homeostatic control of plasma choline concentration. Kidney Int.10, 329 (1976).

    Article  CAS  Google Scholar 

  57. Rose, W. C.: Amino acid requirements of man. Fed Proc8, 546 (1949).

    CAS  Google Scholar 

  58. Russel, D. H., B. G. M. Durie, S. E. Salmon: Polyamines as predictors of success and failure in cancer chemotherapy. Lancet1975/II, 797–799.

    Article  Google Scholar 

  59. Schaefer, K., G. Oftermann, D. von Herroth, et al.: Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients. Clin. Nephrol.14, 81–88 (1980).

    CAS  Google Scholar 

  60. Schneider, W., G. A. Jutzler: Implications of cyclic adenosine 3′5′-mono-phosphate in chronic renal failure. New Engl. J. Med.291, 155 (1974).

    CAS  Google Scholar 

  61. Seale, T. W., W. Y. Chan, J. B. Shukla, et al.: Isolation and characterization of a polyamine-peptide conjugate from human amniotic fluid. Clin. Chim. Acta95, 461–472 (1979).

    Article  CAS  Google Scholar 

  62. Servo, C., A. Bardy, A. Pasternack, E. Pitkänen: Plasma, red cell and cerebrospinal fluid concentrations of myoinositol in patients with severe chronic renal failure. Ann. Clin. Res.8, 374 (1976).

    CAS  Google Scholar 

  63. Simenoff, M. L., J. J. Saukkonen, J. F. Burke, R. W. Schaedler, W. H. Vogel, K. Bovee, N. Lasker: Importance of aliphatic amines in uremia. Kidney Int. 12, Suppl8, 16 (1978).

    Google Scholar 

  64. Slatopolsky, E., K. Martin, K. Hrusk: Parathyroid hormone metabolism and its potential as a uremic toxin, Amer. Phys. Soc. Ed. Rev. 1–12 (1980).

  65. Tabor, H., C. W. Tabor: Spermidine, spermine and related amines. Pharmacol. Rev.16, 245 (1964).

    CAS  Google Scholar 

  66. Walser, M., A. W. Coulter, S. Dighe, F. R. Chantz: The effect of ketoanalogues of essential amino acids in severe chronic uremia. J. Clin. Invest.52, 578 (1973).

    Google Scholar 

  67. Walser, M.: Ketoacids in the treatment of uremia. Clin. Nephrol.3, 180 (1975).

    CAS  Google Scholar 

  68. Ward, R. A., M. J. Shirlow, J. M. Hayes, et al.: Protein catabolism during hemodialysis. Amer. J. Clin. Nutr.32, 2443–2449 (1979).

    CAS  Google Scholar 

  69. Wathen, R., M. Smith, P. Keshaviah, C. Comby, F. Shapiro: Depressed in vitro aggregation of platelets of chronic hemodialysis patients (CH DP): a role for cyclic AMP. Trans. Amer. Soc. Artif. Intern. Organs21, 320 (1975).

    CAS  Google Scholar 

  70. Young, G. A., F. M. Parsons: Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clin. Sci. Mol. Med.45, 89 (1973).

    CAS  Google Scholar 

  71. Young, G. A., J. B. Keogh, F. M. Parsons: Plasma amino acids and protein levels in chronic renal failure and changes caused by oral supplements of essential amino acids. Clin. Chim. Acts61, 205–213 (1975).

    Article  CAS  Google Scholar 

  72. Zimmermann, L., A. Baldesten, J. Bergström, P. Fürst: Isotachophoretic separation of middle molecule peptides in uremic body fluids. Clin. Nephrol.13, 183–188 (1980).

    Google Scholar 

  73. Zimmermann, L., P. Fürst, J. Bergström, H. Jörnvall: A new glycine containing compound with a blocked amino group from uremic body fluids. Clin. Nephrol.14, 107–111 (1980).

    Google Scholar 

  74. Zimmermann, L., H. Jörnvall, J. Bergström, P. Fürst, J. Sjövall: Characterization of a double conjugate in uremic body fluids. Febs Lett.129, 237 (1981).

    Article  Google Scholar 

Download references

Author information

Author notes

  1. P. Fürst

    Present address: Institute for Biological Chemistry and Nutrition, University of Hohenheim, West Germany

Authors and Affiliations

  1. Department of Renal Medicine, Huddinge University Hospital, Karolinska Institutet, Sweden

    A. Alvestrand & J. Bergström

Authors
  1. P. Fürst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Alvestrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Bergström
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fürst, P., Alvestrand, A. & Bergström, J. Recent advances in the pathogenesis and nutritional treatment of chronic uremia. Z Ernährungswiss 21, 175–190 (1982). https://doi.org/10.1007/BF02028811

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02028811

Search

Navigation